The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Cognition Biomarkers, 2013Validation of Novel and Traditional Quantitative EEG Biomarkers
Objective/Rationale:
Cognitive problems commonly add to the disability of the motor symptoms of Parkinson’s disease (PD), but there are no highly effective treatments for cognitive dysfunction in PD... -
Improved Biomarkers and Clinical Outcome Measures, 2019Correlating MRI, Pathology and Cognitive Assessments toward Biomarkers of Cognitive Decline
Study Rationale:
Parkinson’s studies are working to identify magnetic resonance imaging (MRI) biomarkers for early diagnosis, disease severity and progression. However, attempts to explore how brain... -
Defining Cognitive Phenotypes of Parkinson’s Disease, 2011The Relationship Between Cognitive Phenotypes of PD with Visual Hallucinations and 5HT2A Receptors in the Inferotemporal Cortex
Objective/Rationale:
The project aims to understand the mechanisms underlying cognitive deficits that are associated with visual hallucinations (VH) in Parkinson’s disease (PD). We have previously... -
Cognition Biomarkers, 2013Validation of Computer-based Saccade Measures as a Biomarker for Neurocognitive Changes in Parkinson's Disease
Objective/Rationale:
Saccades are fast eye movements that shift visual focus for tasks like reading, visual searching and coordinating safe movement. Research has shown that the speed, accuracy and... -
Research Grant, 2018Safety and Tolerability of GRF6021 Infusions in People with Parkinson's Disease and Cognitive Impairment
Study Rationale & Design:
Components of blood have been found to improve health and enhance multiple biological functions, including brain function, in older animals. Blood plasma has been... -
Cognition Biomarkers, 2013Identification and Validation of Cerebrospinal Fluid Markers Related to Altered Amyloid-beta Processing in the Prediction of Dementia Associated with Parkinson’s Disease
Objective/Rationale:
Patients with Parkinson’s disease (PD) are at increased risk to develop dementia compared with the general population. However, not all patients experience this...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.